Currently, more than 50 percent of medicines used to treat children in Europe have not been specifically tested on them or authorised for their use.
Thus, doctors in the EU are having to guess the best dosage levels for children. New rules will require that all medicines still in the development stages be researched as to the safety and effectiveness of their products in children. (BBC )